A subset of epithelial cells mimics regulatory T cells and contributes to immune evasion during development of pancreatic adenocarcinoma
Pancreatic cancer is refractory to most current treatment options. Immunotherapy emerges as an effective and novel therapeutic strategy for several solid tumors. However, most of the clinical trials on immunot...
Source: BMC Medicine - Category: Internal Medicine Authors: Courtney W. Houchen and Min Li Tags: Commentary Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Clinical Trials | Epithelial Cancer | Immunotherapy | Internal Medicine | Pancreas | Pancreatic Cancer